Story thread · 4 reports / 3 sources
The Surprising Reason EyePoint Just Crashed 69%
investors.com · 2h · first report
How the coverage leans
Across 3 sources · syndicated copies counted once
EyePoint stock crashed Monday after its eye disease treatment, Duravyu, missed the mark in a final-phase study. The post The Surprising Reason EyePoint Just Crashed 69% appeared first on Investor's Business Daily .
The coverage
- EyePoint plummets on pivotal data for main drug
biopharmadive.com · 21m
- Ocular gains on EyePoint phase 3 wet AMD miss
seekingalpha.com · 39m
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.